Strategic partnerships R-Biopharm AG has a history of collaborating with major players and expanded capabilities through acquisitions such as AusDiagnostics and partnerships with Bosch and Gulf Scientific. Sales opportunities exist in offering complementary diagnostics platforms, integration services, and co-marketing arrangements to expand market reach.

Global reach The company operates in over 120 countries with 28 subsidiaries and 120 distributors, presenting a channel-rich landscape for distributors, regional sales reps, and ASPs to expand coverage, support, and localized regulatory compliance offerings.

Allergen leadership As a global market leader in allergen analysis test systems, there is potential to cross-sell upstream R&D services, supply chain analytics, and software solutions (LIMS, data analytics) to enhance allergen testing workflows for clinical diagnostics, nutrition care, and analytics.

Sustainability edge Repeated sustainability recognition and a family-run, long-term growth mindset can be leveraged to pitch sustainable and cost-efficient solutions, including lifecycle management, compliant manufacturing practices, and value-based pricing aligned with quality and safety benefits.

Technology stack fit With SAP FICO, iCIMS, Power BI, AWS, Salesforce Marketing Cloud, and CRM/ERP capabilities in place, there are opportunities to offer additional analytics, cloud-based data integration, and digital transformation services to optimize operations, forecasting, and customer engagement.